Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. May 21, 2013; 19(19): 2935-2940
Published online May 21, 2013. doi: 10.3748/wjg.v19.i19.2935
Published online May 21, 2013. doi: 10.3748/wjg.v19.i19.2935
Patient | Time from RE to symptoms (wk) | Clinical follow-up time (mo) | Symptoms (CTCAE v4.02 grading scale) | Treatment | Weight loss1 (kg) | Hemoglobin2 (g/dL) | Reason for end of endoscopic follow up | ||||
Pain | Nausea and vomiting | Anorexia | Treatment used | Time on treatment (mo) | Clinical response | ||||||
1 | 4 | 6 | Epigastric pain (1) | No | No | Pantoprazole, domperidone and almagate | 4 | Yes | 6 | -1.5 | Improvement |
2 | 4 | 29 | Epigastric pain (1) | Yes (1) | No | Esomeprazole, cinitapride sucralfate and ranitidine | 8 | Yes | 7 | -0.6 | Improvement |
3 | 4 | 88 | Epigastric pain (2) | Yes (1) | Yes (3) | Pantoprazole, metoclopramide, sucralfate and cinitapride | 10 | Yes | 17 | -6.9 | Improvement |
4 | 2 | 9 | Left subcostal pain (2) | Yes (1) | No | Pantoprazole, sucralfate and almagate | 5 | Yes | 4 | -3.1 | Improvement |
5 | 12 | 88 | Epigastric pain (1) | Yes (1) | Yes (2) | Pantoprazole, pentoxifylline, esomeprazole and almagate | 5 | Yes | 4 | -1.6 | Improvement; still on follow-up |
6 | 4 | 3 | Epigastric pain (2) | Yes (2) | Yes (2) | Esomeprazole, pentoxifylline and misoprostole | 1 | No | 4.1 | -2.4 | Exitus |
- Citation: Rodríguez-Lago I, Carretero C, Herráiz M, Subtil JC, Betés M, Rodríguez-Fraile M, Sola JJ, Bilbao JI, Muñoz-Navas M, Sangro B. Long-term follow-up study of gastroduodenal lesions after radioembolization of hepatic tumors. World J Gastroenterol 2013; 19(19): 2935-2940
- URL: https://www.wjgnet.com/1007-9327/full/v19/i19/2935.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i19.2935